Skip to content
Screener

Shattuck Labs, Inc. STTK Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Amgen logo
AmgenAMGN
$00.0%
Avalo Therapeutics logo
Avalo TherapeuticsAVTX
$00.0%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$0.010.0%
AbbVie logo
AbbVieABBV
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE

Other financials

Income statement

See full
Revenue-
Operating income-$16.2M-24.0%
Net income-$15.2M-21.6%
EPS (diluted)-$0.12+50.0%

Balance sheet

See full
Cash & equivalents$63.3M+25.4%
Total debt$2.7M-10.0%
Total equity$211.1M+270%
Total assets$220.7M+243%

Cash flow

See full
Operating cash flow-$10.2M+2.4%
CapEx$78.0K
Free cash flow-$10.3M+1.6%

Valuation

See full
Market cap$694.34M+1,826%
Enterprise value$633.72M-5,241%
P/S694.3×+682×

Profitability

See full
Operating margin-5,578.7%-15,316pp
Net margin-5,256.8%-14,625pp
FCF margin-4,124%-23,818pp

Returns & leverage

See full
Return on equity-39.2%-12.5pp
Debt / equity0.0×
Current ratio27.6×+17.3×

Where this comes from

Reported directly by Shattuck Labs, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The source filing: Shattuck Labs, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 6:57 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055483
Line itemJune 30, 2026December 31,2025
Total liabilities9,5318,636
Commitments and contingencies (Note 5)
Stockholders’ equity:
Common stock, $0.0001 par value: 300,000,000 shares authorized; 100,726,022 shares issued and outstanding at June 30, 2026 and 63,279,843 shares issued and outstanding at December 31, 2025107
Additional paid-in capital671,637512,906
Accumulated other comprehensive (loss) income(63)6
Accumulated deficit(460,448)(430,529)
Total stockholders’ equity211,13682,390

Item 1. Condensed Financial Statements (Unaudited)

FAQ

What is Shattuck Labs, Inc.'s common stock, par value (in dollars per share)?
Shattuck Labs, Inc. (STTK) reported common stock, par value (in dollars per share) of $0 in Q2 2026.
How has Shattuck Labs, Inc.'s common stock, par value (in dollars per share) changed year-over-year?
Shattuck Labs, Inc.'s common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for Shattuck Labs, Inc.'s common stock, par value (in dollars per share)?
Over 5 years (2020 to 2025), Shattuck Labs, Inc.'s common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.
What does common stock, par value (in dollars per share) mean?
Common stock, par value (in dollars per share)

Ask your AI about Shattuck Labs, Inc.'s common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude